WSJ : Qualcomm’s Smartphone Future Looks Brighter With AI

Qualcomm’s Smartphone Future Looks Brighter With AI
AI-enabled smartphones and PCs should help the maker of wireless chips, which remains among the cheapest in semiconductor stocks

The irony of an AI iPhone is that it could also help one company that Apple AAPL 5.98%increase; green up pointing triangle is least interested in helping.

Investors are increasingly enthusiastic about such a device following Apple’s latest earnings. Those results showed a pronounced weakness in iPhone revenue during the March quarter, but that was already expected, and the company cushioned the news with a generous stock buyback. Chief Executive Tim Cook also used the occasion to further tout Apple’s interest in generative artificial intelligence, which has analysts more convinced that an AI-enabled iPhone is on the horizon. Ben Reitzes of Melius Research predicted “an AI-driven iPhone supercycle is likely coming in 2025” in his note to clients. Apple’s shares jumped 6% on Friday, the stock’s best single-day gain in 18 months.

That followed an even better day for Qualcomm QCOM -0.26%decrease; red down pointing triangle. The maker of modem chips used in the iPhone and many other wireless devices saw its stock jump nearly 10% on Thursday after its own March quarter results, where chip sales were helped by AI-enabled Android phones such as Samsung’s latest Galaxy family that went on sale in January.

A growing number of smartphones and personal computers with AI processors and capabilities embedded in the hardware are making their way to the market this year. Such on-device AI offers benefits such as faster speed in processing AI tasks as well as greater privacy—as less data has to go back and forth between the cloud for such tasks. Samsung’s Galaxy S24 phones offer functions such as real-time translating and image-based web search. The market has been receptive; unit sales of the S24 phones during their first three weeks after launch were up 8% from the previous Galaxy family’s sales last year during the same window, according to Counterpoint Research.

The launch of an AI-enabled iPhone would likely further juice the market for on-device AI, given Apple’s marketing prowess. And that would be a major benefit for Qualcomm, even given the two companies’ longstanding animosity. Qualcomm has long dominated the market for modem chips—also known as basebands—that handle the task of connecting a device to a carrier network. Its Snapdragon central processor is also the main computing chip for a variety of Android phones, including the latest from Samsung. And it has a growing business in the RF (radio frequency) chips that work with basebands to filter interference and boost signal strength.

For smartphones processing demanding AI algorithms on the device, the ability of such components to work closely together while conserving power becomes paramount. That plays to Qualcomm’s advantages—particularly among the wireless components that the company has a long-established expertise in. “If AI is in a phone, the computer and memory is going to consume more power,” said TD Cowen analyst Matt Ramsay. “If you want the battery life to be the same, where are you going to get the power budget from? Modem, RF and screen.”

That could even help extend the life of Qualcomm’s contentious business with Apple, which has long been working to get Qualcomm’s chips out of its devices. Apple’s failure to develop its own modem led to the two companies extending their deal last year. Qualcomm is also believed to have won a place for its RF chips in this year’s coming iPhone lineup after chip maker Skyworks told investors during its own quarterly call last week that it lost that socket. In a note to clients, UBS analyst Tim Arcuri said “as time goes on without an Apple modem, Qualcomm’s leverage grows arguably stronger as AI requires much tighter modem/RF integration to keep battery life manageable.”

Qualcomm is also making a major play in AI-enabled PCs, a large number of which are expected to launch later this year. Any share gains in PCs would represent pure upside for the company, as it has little presence there now. Microsoft’s Build conference later this month is expected to showcase many new AI-enabled laptop computers, including models powered by Qualcomm’s Snapdragon processor.

Much remains to be seen about whether on-device AI can actually spark a much-needed boost in sales for smartphones and PCs, two largely mature markets. But unlike many other chip stocks, Qualcomm’s current valuation isn’t reflecting much in the way of AI hype. The shares closed Friday around 17 times forward earnings—a 39% discount to the PHLX Semiconductor Index’s near-decade high multiple of 28.3, according to FactSet. Helping sell a few more smartphones by making them even smarter could go a long way.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • BNTX -4%, THS -3.4%, AMR -2.5%, SHO -1.4%, AXSM -1.1%, CNA -0.9%, SAVE -0.8%
Other news:
  • GLYC -76.8% (announces results of pivotal phase 3 Study of uproleselan in relapsed/refractory (R/R)
  • AML; did not achieve a statistically significant improvement)
  • EYPT -32.9% (topline data from the phase 2 pavia trial of Duravyu in non-proliferative diabetic retinopathy)
  • MPW -15.8% (Steward Health Care finalizing financing deal with Medical Properties Trust to support its restructuring)
  • LAZR -7.7% (files mixed securities shelf offering; confirmed after the close a restructuring plan)
  • ADCT -4.7% (Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA in Patients with Relapsed/Refractory Marginal Zone Lymphoma; agreed to sell, by way of an underwritten offering, 13,411,912 of its common shares at a price of $4.90/share)
  • MTH -3.1% (commenced an offering of $500 mln aggregate principal amount of its Convertible Senior Notes due 2028)
  • SO -2.5% (offering of $1.1 billion in aggregate principal amount of Convertible Senior Notes due June 15, 2027)
  • PAC -2.3% (reports April traffic)
  • BMRN -2.3% (reports New Data for BioMarin's VOXZOGO (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting)
  • ADTN -1.7% (to take a $293 mln goodwill impairment charge in Q1)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • FRPT +11.1%, BCRX +9.4%, L +4%, JLL +2.7%
Other news:
  • PRFT +52.5% (to be Acquired by EQT for $76.00 per share; also reported earnings)
  • ZTEK +10.6% (subsidiary Triera Biosciences prioritized the development of a prophylaxis and therapeutic for highly pathogenic avian influenza and reports initial test results)
  • LILM +8.7% (files for 75 mln share offering by selling shareholder)
  • HIMS +5.7% (CEO says that he "in no way condone nor support acts or threats of violence, antisemitism, or intimidation and there is absolutely no justification for violence on our campuses")
  • XERS +4.8% (has entered into an exclusive worldwide collaboration and license agreement with Beta Bionics for the development and commercialization of a glucagon product utilizing Xeris' XeriSol technology for use in Beta Bionics' proprietary bi-hormonal pump and pump systems)
  • VST +4.4% (to join S&P 500)
  • MNMD +3.9% (Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder)
  • HUT +3.9% (provides operations update for April)
  • CLLS +3.7% (Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca (AZN))
  • URGN +3.2% (reports New Real-World Retrospective Analysis Presented at AUA 2024 Reports 86% Recurrence-Free Survival (RFS) at 24 Months with JELMYTO Across All Studied Patient and Disease Characteristics in Cohort of Responders to Induction Therapy; Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024)
  • MNKD +3% (receives FDA fast track designation for clofazimine inhalation suspension for the treatment of nontuberculous mycobacterial lung disease)
  • VZLA +2.9% (has now issued 448,137 common shares for the previously announced asset purchase agreement dated March 5, 2024, entered into with Inca Azteca Gold S.A.P.I. de C.V)
  • REVG +1.9% (favorable research report from Alta Fox)
  • WT +1.7% (sends letter to stockholders urging full support of the current board to continue the company's strong momentum)
  • X +1.6% (EU Commission clears acquisition of US Steel by Nippon Steel)
  • VALE +1.2% (informs on settlement proposal)
  • CLF +1.1% (unit received an Order from MSHA at the Company's operations in Michigan)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • PRFT +52.8%, ADCT +30.4%, VST +5%, CLLS +4%, L +4%, URGN +3.2%, LILM +1.9%, ABR +1.5%, VALE +1.5%, CLF +1.5%, MNMD +1.2%, BRK.B +1.2%
  • Gapping down:
    • GLYC -56.9%, LAZR -8.9%, IART -6.5%, SAVE -5.7%, PAC -2.3%, MNKD -1.8%, AZN -1.2%, BMRN -1.1%

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Banco Santander Brasil (BSBR) upgraded to Buy from Neutral at BofA Securities
    • Bausch + Lomb (BLCO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $18
    • Blueprint Medicines (BPMC) upgraded to Market Perform from Underperform at Leerink Partners; tgt raised to $97
    • Camden Property (CPT) upgraded to Neutral from Underweight at Piper Sandler; tgt raised to $110
    • Chemomab Therapeutics (CMMB) upgraded to Outperform from Perform at Oppenheimer; tgt $6
    • CytomX Therapeutics (CTMX) upgraded to Buy from Hold at Jefferies; tgt raised to $8
    • Glaukos (GKOS) upgraded to Buy from Hold at Jefferies; tgt raised to $125
    • Melco Resorts & Entertainment (MLCO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $9.60
    • Micron (MU) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $150
    • Mid-America Aptmt (MAA) upgraded to Outperform from Neutral at Wedbush; tgt raised to $154
    • Sensata Tech (ST) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $60
    • Silicon Motion (SIMO) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $88
    • U.S. Steel (X) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt lowered to $48
    • Wolverine (WWW) upgraded to Buy from Neutral at Seaport Research Partners; tgt $15
  • Downgrades:
    • Comerica (CMA) downgraded to Neutral from Buy at Citigroup; tgt $56
    • Johnson Controls (JCI) downgraded to Neutral from Buy at UBS; tgt lowered to $68
    • Peloton (PTON) downgraded to Neutral from Buy at Citigroup; tgt lowered to $4
    • Ryan Specialty Group (RYAN) downgraded to Peer Perform from Outperform at Wolfe Research
    • Uniti Group (UNIT) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $6
    • Victoria's Secret (VSCO) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $15
  • Others:
    • EHang (EH) initiated with an Overweight at Morgan Stanley; tgt $27.50
    • enCore Energy Corp. (EU) initiated with a Buy at H.C. Wainwright; tgt $7.50
    • Eton Pharmaceuticals (ETON) initiated with a Buy at Craig Hallum; tgt $8
    • Flutter Entertainment (FLUT) initiated with a Buy at MoffettNathanson; tgt $240
    • Citigroup opened 90-day Positive Catalyst Watch on Hancock Whitney (HWC)
    • Jasper Therapeutics (JSPR) initiated with a Buy at H.C. Wainwright; tgt $65
    • PACS Group (PACS) initiated with an Outperform at RBC Capital Mkts; tgt $30
    • PACS Group (PACS) initiated with a Buy at Truist; tgt $32
    • PACS Group (PACS) initiated with an Outperform at Oppenheimer; tgt $31
    • PACS Group (PACS) initiated with a Buy at Citigroup; tgt $32
    • PACS Group (PACS) initiated with an Overweight at JP Morgan; tgt $27
    • PACS Group (PACS) initiated with an Overweight at Stephens; tgt $31

>>> Europe : Brokers Upgrades & Downgrades - 6th of May 2024 V3(++)

>>> Up
* A2A Raised to Buy at Intesa Sanpaolo; PT 2.10 euros (+)
* AMD Raised to Buy at Phillip Secs; PT $190
* Know IT Raised to Buy at Nordea; PT 198 kronor
* Micron Raised to Outperform at Baird; PT $150
* Pihlajalinna Raised to Buy at Nordea; PT 10 euros
* Raute Raised to Buy at Inderes; PT 12.50 euros
* U.S. Steel Raised to Overweight at Morgan Stanley; PT $48
* Vaisala Raised to Accumulate at Inderes; PT 39 euros

>>> Down
* 2020 Bulkers Cut to Sell at DNB Markets; PT 154 kroner (+)
* Avance Gas Cut to Hold at DNB Markets; PT 172 kroner (+)
* Bergman & Beving Cut to Hold at Handelsbanken (+)
* Castellum Cut to Hold at DNB Markets; PT 135 kronor (+)
* Golden Ocean Cut to Sell at DNB Markets; PT 140 kroner (+)
* Mentice Cut to Hold at Pareto Securities; PT 34 kronor
* Peloton Cut to Neutral at Citi; PT $4
* Salmar Cut to Hold at Pareto Securities; PT 700 kroner
* Scandi Standard Cut to Hold at TP ICAP Midcap; PT 72 kronor (+)
* Valiant Cut to Hold at Kepler Cheuvreux; PT 110 Swiss francs (++)
* Victoria's Secret Cut to Underweight at Morgan Stanley; PT $15
* Zignago Vetro Cut to Hold at Intesa Sanpaolo; PT 14.50 euros (++)

>>> Initiation
* Colruyt Reinstated Reduce at Kepler Cheuvreux; PT 40 euros (++)
* Hemnet Rated New Buy at ABG; PT 360 kronor
* Karnell Group Rated New Buy at SEB Equities; PT 45 kronor
* Northern Data Rated New Buy at B Riley; PT 36 euros
* Telefonica Reinstated Underperform at BNPP Exane; PT 3.30 euros

>>> Call
* Investors Not Pricing US Election Volatility Risks, Goldman Says (+)
* Morgan Stanley’s Wilson Likes Quality Stocks on Uncertain Macro (+)

>>> Europe : Brokers Upgrades & Downgrades - 6th of May 2024 V2(+)

>>> Up
* A2A Raised to Buy at Intesa Sanpaolo; PT 2.10 euros (+)
* AMD Raised to Buy at Phillip Secs; PT $190
* Know IT Raised to Buy at Nordea; PT 198 kronor
* Micron Raised to Outperform at Baird; PT $150
* Pihlajalinna Raised to Buy at Nordea; PT 10 euros
* Raute Raised to Buy at Inderes; PT 12.50 euros
* U.S. Steel Raised to Overweight at Morgan Stanley; PT $48
* Vaisala Raised to Accumulate at Inderes; PT 39 euros

>>> Down
* 2020 Bulkers Cut to Sell at DNB Markets; PT 154 kroner (+)
* Avance Gas Cut to Hold at DNB Markets; PT 172 kroner (+)
* Bergman & Beving Cut to Hold at Handelsbanken (+)
* Castellum Cut to Hold at DNB Markets; PT 135 kronor (+)
* Golden Ocean Cut to Sell at DNB Markets; PT 140 kroner (+)
* Mentice Cut to Hold at Pareto Securities; PT 34 kronor
* Peloton Cut to Neutral at Citi; PT $4
* Salmar Cut to Hold at Pareto Securities; PT 700 kroner
* Scandi Standard Cut to Hold at TP ICAP Midcap; PT 72 kronor (+)
* Victoria's Secret Cut to Underweight at Morgan Stanley; PT $15

>>> Initiation
* Hemnet Rated New Buy at ABG; PT 360 kronor
* Karnell Group Rated New Buy at SEB Equities; PT 45 kronor
* Northern Data Rated New Buy at B Riley; PT 36 euros
* Telefonica Reinstated Underperform at BNPP Exane; PT 3.30 euros

>>> Call
* Investors Not Pricing US Election Volatility Risks, Goldman Says (+)
* Morgan Stanley’s Wilson Likes Quality Stocks on Uncertain Macro (+)

FT : Eurotunnel operator offers to subsidise new cross-Channel rail services

Eurotunnel operator offers to subsidise new cross-Channel rail services
Getlink chief puts forward €50mn pot for companies considering launching rivals to Eurostar

The operator of the Channel Tunnel has offered €50mn in support to encourage companies to open new cross-Channel rail services to rival Eurostar.

Yann Leriche, Getlink chief executive, said at least five companies are “seriously” interested in starting new passenger trains between the UK and Europe, and that the barriers to entry have decreased in recent years.

Sir Richard Branson’s Virgin Group, a consortium backed by the largest shareholders in Mobico, formerly known as National Express, and Dutch start-up Heuro have all said they are considering launching services, and Leriche said there are at least two other contenders.

“We have a lot of room, including at peak times. I think there is a potential to have more high speed trains and freight trains,” he told the Financial Times.

Getlink, formerly known as Eurotunnel, manages and operates the infrastructure of the Channel Tunnel and also operates the LeShuttle passenger and freight trains.

Leriche believes there is space for more than one new operator, and the money could be split between new entrants. Overall, around 400 trains a day use the tunnel, which has capacity for 1,000. The actual usage is below the forecasts when the tunnel was opened 30 years ago.

Getlink and HS1, which operates the high-speed lines from Kent to London, have long pushed for more operators to launch services.

Leriche said Getlink has earmarked at least €50mn to spend over the next five years in direct subsidies to support any new operator launching a service.

The money would be available once the new service is launched to help operators with the initial high running costs of launching a new train service. Getlink previously supported Eurostar when it began nonstop trains between London and Amsterdam.

“There are still hurdles [to launching a new service], but they used to be quite high, and now they are very limited,” Leriche said.

Among the biggest challenges to any new entrant is the cost of ordering modified trains to comply with the tunnel’s stringent safety rules, including increased fire resistance.

Leriche said this critical hurdle has been cleared after Alstom’s new TGV trains were certified to run through the tunnel, meaning a new operator could buy trains off the shelf, “massively” reducing expenditure.

Getlink has also worked with national regulators to streamline the regulatory process to certify new operators, and believes there is demand for 4mn passenger journeys a year from Germany and Switzerland, on top of Eurostar’s current routes from London to Paris, Brussels and Amsterdam.

Evolyn, a Spanish-led project backed by the billionaire Cosmen industrialist family, an investor in Mobico, has announced a preliminary agreement, but not a final deal, to buy new trains from Alstom. Mobico itself held talks over joining the consortium, but opted not to.

Separately, Leriche said he is confident there will be no significant disruption to passenger services from the introduction of new EU biometric border controls due to be introduced this year.

The UK’s leading logistics body has warned Channel ports could “grind to a halt” as a result of the control, which will require passengers to register details including fingerprints at passport control.

Leriche said Getlink has invested €80mn in new border facilities, and has the space to handle the new logistics.

Getlink is also considering opening new inland lorry terminals, to allow vehicles to leapfrog congestion in Kent and northern France.

This would mark a significant shift for the company, which currently only operates stations at the near the entrances of the tunnel near the English Channel.

As Getlink diversifies its business, it has also held talks with the UK and French governments over adding more cables to carry electricity to connect energy markets in the UK and the continent.